Delivery Order SPE2DB22D2206-SPE2DB24FHY25

Award Date 6/26/24
Potential Completion Date 6/27/24
Potential Value $42K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to AmerisourceBergen Drug Corp is a delivery order issued by the Defense Logistics Agency (DLA) for the supply of ENBREL 50 MG/ML SURECLICKML, a pharmaceutical product. The contract has a firm fixed price of $12,510.54 and a period of performance through February 26, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range of...
This federal contract award to Amerisourcebergen Drug Corp, through its Corporate Office division, is a delivery order valued at $66,259.65 for the provision of ENBREL 50 MG/ML SURECLICKML pharmaceutical products. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical and does not have a set-aside designation. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was issued by the Defense Logistics Agency (DLA) for the supply of ENBREL 50 MG/ML SURECLICKML, a specialty pharmaceutical product. The $13,022.74 firm fixed-price delivery order contract has an ultimate completion date of January 6, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to...
This federal contract award is for the delivery of ENBREL 50 MG/ML SURECLICK, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $56,647.25 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a period of performance through May 3, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $49,508.57 fixed-price delivery order contract is for the supply of ENBREL 50 MG/ML SURECLICKML, a specialty medication. The contract has an ultimate completion date of January 17, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to AmerisourceBergen Drug Corp is a delivery order worth $16,394.75 for ENBREL 50 MG/ML SURECLICKML, a specialty pharmaceutical product. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of February 10, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA). The $14,419.64 delivery order is for the supply of ENBREL 50 MG/ML SURECLICKML, a pharmaceutical product, with a performance period extending through May 9, 2025. The contract is a firm-fixed-price delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp also holds a significant...
This federal contract award, valued at $144,750.92, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the supply of ENBREL 50 MG/ML SURECLICKML, a medication, with a performance period extending through April 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is a delivery order valued at $46,620.88 awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ENBREL 50 MG/ML SURECLICKML, a specialty medication, with a period of performance through December 19, 2024. This delivery order is placed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $49,654.34 firm fixed-price delivery order is for the supply of ENBREL 50 MG/ML SURECLICKML, a specialty medication. The contract has an ultimate completion date of February 18, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FHY25
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a delivery order worth $42,155.77 for the supply of ENBREL 50 MG/ML SURECLICK medication. The contract is awarded by the Defense Logistics Agency (DLA), a defense agency that provides logistics, acquisition, and technical services to the U.S. Armed Forces and other government agencies. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities worldwide. This specific delivery order is not set aside and was awarded on a full and open competition basis, highlighting Amerisourcebergen's competitive position in the federal pharmaceutical supply market.

Generated 9/25/24, 9:19 AM